In 2017, Western medicine preparations achieved a significant increase in the EU and North American markets, and the increase was much higher than in the traditional African, Asian and South American markets. The EU market grew by 27.82%, and the North American market increased by 15.90%, of which the US grew by 14.8%. The growth rate for the UK is 34.41%, for Switzerland it is 762.87%, for Spain it is 23.34%. For Huahai Pharmaceuticals, Hengrui Pharmaceuticals has a large share. Shenzhen Tiandao Pharmaceuticals Co., Ltd. has achieved explosive growth and exported US$54 million to Europe and the United States respectively. , 17.33 million US dollars, become the biggest bright spot.
2017 Formulation exports to European and American pharmaceutical companies
1. Zhejiang Huahai Pharmaceutical Co., Ltd.
2. Jiangsu Hengrui Pharmaceutical Co., Ltd.
3. Shenzhen Tiandao Pharmaceutical Co., Ltd.
4. Oriental International Group Shanghai Rongheng International Trade Co., Ltd.
5. People Fupu Ke Pharmaceutical (Wuhan) Co., Ltd.
6. Anhui Huaan Import and Export Co., Ltd.
7. Qilu Pharmaceutical Co., Ltd.
8. Shijiazhuang Ouyi Pharmaceutical Co., Ltd.
9. Guilin South Pharmaceutical Co., Ltd.
10. Shenzhen Zhijun Pharmaceutical Trade Co., Ltd.
At present, China's preparation exports have shifted from the traditional Asian, African, and South American markets to the European and American markets. This has become a clear trend, and the standardized pharmaceutical market is increasingly valued by domestic pharmaceutical companies, especially high-end pharmaceutical companies.
The main reasons for the analysis were as follows: First, the European and American pharmaceutical market was standardized, the threshold was high, and there was a healthy competitive environment. Many pharmaceutical companies had successive varieties of products to gain access to Europe and the United States, and prepared for market entry. In 2017, Chinese pharmaceutical companies obtained US ANDA30; The European and American markets have higher profits and the market is stable, which is higher than those in Africa and Asia. Third, the market for generic drugs in Europe and the United States has large room for growth. Sales of generic drugs are expected to maintain sustained growth; Fourth, high standards for European and American pharmaceutical preparations are favorable for companies. Product expansion to the global market.
Click on the image below to register for the exhibition!
